tm logo
INSMED
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 16 Jun 2014

Last Applicant/ Owned by

9 Deer Park Drive, Suite C

Monmouth Junction

NJ

08852

Serial Number

85011369 filed on 12th Apr 2010

Registration Number

N/A

Correspondent Address

Peter J. Willsey

PETER J. WILLSEY

1299 Pennsylvania Avenue, NW, Suite 700

WASHINGTON DC 20004

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

INSMED

Pharmaceutical and biological preparations for clinical medical use, namely, for use in IGF-I deficiency, growth hormone insensitivity syndrome, growth disorders, severe burns, severe insulin resistance, Type 2 diabetes, Type 1 diabetes, muscular dystrophies, amyotrophic lateral sclerosis, retinopathy of prematurity, osteoporosis, and AIDS adipose redistribution syndrome; inoculations for use in t Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Chemical, scientific and medical research; laboratory research in the field of biochemistry, pharmacology and endocrinology

Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for clinical medical use, namely, for use in IGF-I deficiency, growth hormone insensitivity syndrome, growth disorders, severe burns, severe insulin resistance, Type 2 diabetes, Type 1 diabetes, muscular dystrophies, amyotrophic lateral sclerosis, retinopathy of prematurity, osteoporosis, and AIDS adipose redistribution syndrome; inoculations for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflammatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects

Class [016]
Paper Goods and Printed Material


Prints; educational publications, namely, training manuals in the field of science and medicine; magazines in the field of science and medicine

Mark Details


Serial Number

No 85011369

Mark Type

No Service Mark

Attorney Docket Number

No 315953-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Jun 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
16th Jun 2014ABANDONMENT - NO USE STATEMENT FILED
07th Nov 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th Nov 2013EXTENSION 5 GRANTED
28th Oct 2013EXTENSION 5 FILED
28th Oct 2013TEAS EXTENSION RECEIVED
20th Apr 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Apr 2013EXTENSION 4 GRANTED
17th Apr 2013EXTENSION 4 FILED
17th Apr 2013TEAS EXTENSION RECEIVED